IL1B and hepatocellular carcinoma: In early twice daily dosed treated HCC mice, a (partial) loss of significant induction of IL1β, TNFα, CCL2, CCR2, Caspase 1 and NLRP3 in the HCC lesions could be observed (Fig. 8a).